• +1 (833) 223 1011
  • sales@milehighlabs.com
Browse FAQs ↓

Your Resource for Cannabinoid Ingredient Knowledge

Learn more about Mile High Labs products, manufacturing processes, testing standards, and how we support partners worldwide.

Cannabinoid Basics

Where does CBD come from?

CBD is derived from hemp plants cultivated specifically for cannabinoid production. Hemp is legally defined as cannabis containing no more than 0.3% THC.

CBD interacts with the body’s endocannabinoid system (ECS), a regulatory network involved in maintaining balance across many physiological processes.

CBD interacts indirectly with receptors involved in neurological signaling. Unlike THC, it does not produce intoxicating effects.

Cannabinoids are naturally occurring compounds found in hemp that interact with the body’s endocannabinoid system.

The ECS is a regulatory network that supports balance across immune, nervous, and metabolic systems.

CBD is non‑intoxicating, while THC is the compound primarily responsible for the psychoactive effects associated with cannabis.

No. CBD does not produce the psychoactive effects commonly associated with THC.

Product Education

What does 'water soluble' mean in your ingredients?

Water‑soluble ingredients are engineered to disperse evenly in liquids, improving formulation consistency and allowing cannabinoids to be used more easily in beverage and liquid applications.

CBD isolate is a highly refined cannabinoid ingredient that contains ≥ 98% cannabidiol. It is commonly used when formulations require a single‑compound cannabinoid with high purity and consistency.

CBC is a naturally occurring cannabinoid derived from the cannabis plant. CBC isolate is produced through a purification process that converts CBCA into CBC through decarboxylation.

CBD tinctures are typically taken sublingually (under the tongue), where the liquid is absorbed through mucous membranes before entering the bloodstream.

Distillates contain a range of cannabinoids and plant compounds, while isolates contain a single purified cannabinoid.

Water solubility refers to the ability of CBD to disperse evenly in water-based systems, which can help improve formulation stability in beverages and liquid products.

This formulation combines CBD isolate with Ashwagandha extract in a water‑soluble liquid format designed to support flexible serving sizes and diverse product applications.

Testing, Quality & COAs

Why is third‑party testing important?

Independent laboratories verify ingredient identity, potency, and safety.

A COA is a laboratory report that confirms potency, cannabinoid content, and contaminant screening for a specific batch.

Customers should review lot numbers, potency values, and contaminant screening results to confirm product specifications.

Testing commonly includes residual solvents, heavy metals, pesticides, and microbial contaminants.

Consistency is supported through standardized manufacturing processes and quality control procedures.

Analytical testing has a small margin of uncertainty due to instrumentation and sample preparation. Daily calibration and validated methods help maintain accuracy.

Manufacturing & Capabilities

Where are Mile High Labs products manufactured?

Products are manufactured in-house at Mile High Labs facilities.

Operations follow cGMP‑aligned systems and documented quality procedures.

Mile High Labs utilizes validated extraction and refinement processes depending on the ingredient type.

Yes. The team supports custom ingredient and finished goods development.

Please reach out to our sales team to set something up today. 

Yes. Mile High Labs supports large‑scale production and high‑volume supply requirements.

No. Mile High Labs focuses on cannabinoid ingredient manufacturing rather than raw hemp sales.

Ordering, Pricing & Samples

How do I purchase Mile High Labs products?

Customers can contact the Mile High Labs sales team to discuss product needs, availability, and ordering.

Qualified partners may request samples by contacting the Mile High Labs sales team.

Pricing varies based on order volume and product specifications.

Shipping, Documentation & Logistics

Do you ship internationally?

Yes. Mile High Labs supports global shipping where regulations permit.

Operations follow cGMP‑aligned systems and documented quality procedures.

Yes. Mile High Labs has supported distribution in European markets.

Distribution availability may depend on evolving regulatory approvals.

Orders are shipped through approved logistics partners.

Tracking information is provided once shipments leave the facility.

Each shipment includes lot numbers that correspond directly to COA documentation.

Typical documentation includes COAs and standard shipping paperwork.

Partners & Resellers

Can I work with Mile High Labs as a distributor or reseller?

Partnership opportunities are evaluated case by case.

Yes. Mile High Labs supports finished goods manufacturing and private label partnerships.

Partners may receive formulation, technical, and quality guidance.

Careers & Company Culture

What is it like to work at Mile High Labs?

Mile High Labs promotes a collaborative, quality‑focused work environment.

Departments may include manufacturing, quality, operations, and commercial teams.

Opportunities may vary depending on season and department needs.

Additional Questions

What is your approach to sustainability?

Sustainability is evaluated across sourcing, manufacturing efficiency, and waste reduction.

Ingredients should be stored according to provided specifications to maintain quality.

Yes. Mile High Labs ingredients are designed to support a wide range of regulated product categories.

Regulatory Landscape & Compliance

Why is compliance now the defining factor in the CBD industry?

Because the market is shifting from a “wellness gold rush” to a regulated, safety-first category. Regulators are enforcing:

  • Standardized dosing
  • Toxicology-backed safety data
  • THC thresholds
  • Product traceability

Companies that fail to comply risk delisting, reformulation, or exit from key markets.

  • UK: Novel Foods regime led by the Food Standards Agency (FSA)
  • EU: EFSA Novel Foods (more stringent, slower approvals)
  • US: Fragmented, state-by-state with no unified FDA pathway
  • Asia (e.g. Japan): Highly controlled but opening to compliant imports

The UK is currently one of the most advanced and structured CBD regulatory environments.

CBD ingestibles are classified as novel foods, meaning companies must submit:

  • Toxicological data
  • Stability data
  • Manufacturing consistency evidence

Without approval, products cannot legally remain on shelves.

  • 10 mg/day CBD acceptable intake
  • 0.07 mg/day THC limit
  • Strict labeling and reformulation requirements

These thresholds are forcing widespread reformulation across the industry.

Because companies must reformulate and relabel per market, increasing:

  • Cost
  • Time-to-market
  • Compliance risk

For example, the US lacks federal clarity while the UK/EU demand full safety dossiers.

Industry Trends & Strategic Shifts

What are regulators prioritizing in 2026?
  • Consumer safety (dose limits, toxicology)
  • Product standardization
  • Clinical validation
  • Supply chain transparency

This is pushing the industry toward pharma-grade standards.

  • Compliance is becoming a barrier to entry:

    • Smaller brands struggle with cost of data generation
    • Non-compliant SKUs are being removed
    • Large, compliant suppliers gain market share

A regulatory-ready company has:

  • Approved or near-approved Novel Food dossiers
  • Validated manufacturing processes
  • Stable formulations within THC/CBD limits
  • Full traceability and documentation

Why is MHL uniquely positioned to lead?

Why is Mile High Labs uniquely positioned in regulated markets?

  • Because it invested early in compliance infrastructure, including:

    • Proprietary toxicology and safety data
    • GMP and ISO-certified manufacturing
    • Full Novel Foods dossier development

    This allows it to operate ahead of regulatory enforcement rather than react to it.

  • First hemp-derived CBD ingredient manufacturer to reach UK Novel Foods risk management phase
  • Among the most advanced applicants in the FSA pipeline

This signals near-term authorization readiness.

It offers:

  • Pre-validated, compliant ingredients
  • Reformulation-ready solutions
  • Regulatory guidance and documentation

This effectively outsources compliance risk for partner brands.

  • Coverage across 12 validated end-use categories (far more than competitors)
  • Broad application: beverages, confectionery, supplements, etc.
  • Enables faster SKU expansion under one compliant supplier

Regulations are tightening THC thresholds globally.

Mile High Labs engineered solutions (e.g., THC-free isolates) before enforcement required it, avoiding:

  • Reformulation costs
  • Product recalls
  • Compliance delays

Owning manufacturing and supply chain allows:

  • Consistent quality control
  • Faster regulatory adaptation
  • Lower dependency on third parties

This is critical in a compliance-heavy environment.

Owning manufacturing and supply chain allows:

  • Consistent quality control
  • Faster regulatory adaptation
  • Lower dependency on third parties

This is critical in a compliance-heavy environment.

Unlike competitors relying on shared or consortium data:

  • Mile High Labs generated its own toxicology and safety datasets

This gives:

  • Greater regulatory control
  • Faster approval pathways
  • Stronger defensibility
  • Faster market access
  • Retailer confidence
  • Long-term shelf stability
  • Ability to scale globally

In regulated markets, compliance = distribution power.

Strategic partnerships enhance:

  • Scientific credibility
  • Formulation innovation
  • Entry into mainstream CPG channels

Forward Focused Questions

What will define the winners in CBD over the next 3–5 years?
  • Regulatory approvals
  • Clinical validation
  • Scalable, compliant supply chains
  • Global market access

Yes—compliance costs will drive:

    • Consolidation of smaller brands
    • Dominance of compliant ingredient suppliers
    • Strategic partnerships with large CPG/pharma players

It’s converging into a hybrid model:

  • Pharma-level compliance
  • FMCG-level distribution

Companies bridging both (like Mile High Labs) are best positioned.

Shopping Cart